Camrelizumab successfully treated a patient with hepato-pulmonary metastasis of gastric cancer: a case report and literature review

Abstract The application of camrelizumab in gastrointestinal tumors is in ongoing clinical trials and has shown good outcomes, which provides a new idea for the diagnosis, treatment and research of gastric cancer. A 70-year-old male patient with advanced gastric cancer developed liver and lung metastasis one year after laparoscopic-assisted radical total gastrectomy, despite postoperative trastuzumab and conventional chemotherapy. To treat this metastatic tumor, camrelizumab was started on August 8, 2019. On November 11, 2020, a CT review showed significantly reduced multiple liver metastases as well as nodules in the left upper lung. At the same time, patients had achieved free progression survival of 16 months and overall survival of more than 31 months. This case report provides a new and strong evidence for the treatment of hepato-pulmonary metastasis with camrelizumab in gastric cancer.